Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TROPOS trial of tralokinumab for oral corticosteroid reduction in severe asthma
NL-OMON44438Phase 3Active, not recruiting
- Sponsor
- Site Management & Monitoring
- Start
- Apr 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in severe asthma and asthma comparing Tralokinumab with Placebo (2 arms). Primary endpoint: Percent change from baseline in daily average oral corticosteroid dose at week 40 without loss of asthma control. Started Apr 2015; status: active, not recruiting.
02
Drugs
tralokinumab
03
Conditions
severe asthmaasthma
Beyond the preview
Go deeper on NL-OMON44438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44438.